<DOC>
	<DOCNO>NCT01766206</DOCNO>
	<brief_summary>A multicenter , single arm , post-marketing surveillance study . This study postlicensure requirement Korea Food Drug Administration ( KFDA ) provide continue safety evaluation MenACWY Korean population 2 month 55 year age , receive MenACWY-CRM vaccination accord routine clinical practice prescribe information .</brief_summary>
	<brief_title>Safety One Dose Meningococcal ACWY Conjugate Vaccine Subjects From 2 Months 55 Years Age Republic South Korea</brief_title>
	<detailed_description />
	<mesh_term>Meningococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Lactitol</mesh_term>
	<criteria>Individuals eligible enrolment study : 1. male female subject 2 month 55 year age time Visit 1 ( include 55 year old subject , one day 56th year birthday ) , schedule receive vaccination MenACWYCRM conjugate vaccine , accord local prescribing information routine clinical practice ; 2. nature study describe subject subject 's parent/legal representative provide write informed consent ; 3. investigator believe subject comply requirement protocol ( e.g. , completion Diary Card ) ; 4. good health determine outcome medical history , physical assessment clinical judgment investigator . 1 . Contraindication , special warning and/or precaution , evaluate investigator , report MenACWYCRM conjugate vaccine Korean prescribing information . In particular , include study subject ever : allergic reaction active substance ingredient study vaccine ; allergic reaction diphtheria toxoid ; illness high fever ; however , mild fever upper respiratory infection ( example cold ) reason delay vaccination . Special care take subject haemophilia problem may stop blood clot properly , person receive blood thinner ( anticoagulant ) .</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>conjugate vaccine</keyword>
	<keyword>phase IV clinical trial</keyword>
	<keyword>Neisseria meningitidis</keyword>
</DOC>